RAPT
RAPT Therapeutics Inc
NASDAQ: RAPT · HEALTHCARE · BIOTECHNOLOGY
$58.02
+0.00% today
Updated 2026-03-04
Market cap
$1.68B
P/E ratio
—
P/S ratio
411.22x
EPS (TTM)
$-11.66
Dividend yield
—
52W range
$6 – $58
Volume
3.2M
RAPT Therapeutics Inc (RAPT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $50.39M | $69.61M | $84.60M | $118.97M | $198.64M | $266.21M | $173.33M | $240.32M |
| Cash & equivalents | $47.52M | $63.80M | $77.38M | $24.92M | $24.03M | $38.95M | $47.48M | $169.74M |
| Current assets | $48.24M | $65.06M | $80.51M | $115.60M | $192.97M | $252.69M | $161.78M | $235.24M |
| Total liabilities | $112.80M | $5.61M | $11.48M | $14.79M | $12.26M | $21.04M | $26.29M | $50.42M |
| Current liabilities | $3.25M | $4.64M | $9.26M | $11.74M | $9.60M | $14.22M | $21.84M | $48.35M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | $-62.41M | $64.00M | $73.12M | $104.18M | $186.38M | $245.17M | $147.03M | $189.90M |
| Retained earnings | $-82.81M | $-118.95M | $-161.95M | $-214.84M | $-284.05M | $-367.88M | $-484.68M | $-614.55M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |